Literature DB >> 21733082

The role of the innate immune recognition system in the pathogenesis of primary biliary cirrhosis: a conceptual view.

Peter A Berg1.   

Abstract

The aetiology of primary biliary cirrhosis (PBC) remains unknown. Infectious and non-infectious noxious insults in combination with tissue-specific factors may precipitate PBC. Activation of innate immune response because of impending danger signals seems to be a key event in early PBC, as evidenced by granuloma formation, eosinophilic reaction and IgM elevation. Aberrant mitophagy in 'stressed' biliary epithelia cells may initiate the immune response against mitochondrial antigens. Antimitochondrial autoantibodies recognize evolutionarily conserved molecules. The question arises, whether they are pathogenic or rather an expression of beneficial autoimmunity. The generally stable course of PBC suggests that stimulatory and inhibitory autoimmune reactions govern the inflammatory biliary process. Tissue repair and defense are the heart of innate immunity. But continuous exposure of exogenous stimuli may precipitate functional antireceptor autoantibodies that are no more protective but rather harmful. Mitophagy, apoptosis and bile duct proliferation define the inflammatory response within bile ducts. Autoantigens may be clustered in different blebs on the surface of apoptotic cells targeting a variety of membrane and non-membrane-associated antigens. Thus, the autoantibody response in PBC may target, for instance, the pro- and anti-apoptotic proteins of the Bcl-2 family or receptors of the adrenergic or cholinergic system, hereby interfering with the programme of apoptosis and the proliferation of biliary epithelial cells. Consideration of there being functional autoantibodies into the pathogenesis of PBC may help to improve our understanding of the aetiopathogenesis of PBC.
© 2011 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21733082     DOI: 10.1111/j.1478-3231.2011.02457.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  9 in total

1.  Emerging views of mitophagy in immunity and autoimmune diseases.

Authors:  Ye Xu; Jun Shen; Zhihua Ran
Journal:  Autophagy       Date:  2019-04-21       Impact factor: 16.016

2.  The role of natural killer (NK) and NK T cells in the loss of tolerance in murine primary biliary cirrhosis.

Authors:  S Shimoda; K Tsuneyama; K Kikuchi; K Harada; Y Nakanuma; M Nakamura; H Ishibashi; S Hisamoto; H Niiro; P S C Leung; A A Ansari; M E Gershwin; K Akashi
Journal:  Clin Exp Immunol       Date:  2012-06       Impact factor: 4.330

3.  The expression and clinical significance of serum IL-17 in patients with primary biliary cirrhosis.

Authors:  Qiannan Sun; Qian Wang; Ning Feng; Yan Meng; Bin Li; Demei Luo; Xiaoqian Shang; Jie Lv; Ahmad Maqsuod Monsaf; Changmin Wang; Xiumin Ma
Journal:  Ann Transl Med       Date:  2019-08

4.  The role of the innate immune system in granulomatous disorders.

Authors:  Helen J Petersen; Andrew M Smith
Journal:  Front Immunol       Date:  2013-05-24       Impact factor: 7.561

5.  Anti-mitochondrial M2 Antibodies Enhance the Risk of Supraventricular Arrhythmias in Patients with Elevated Hepatobiliary Enzyme Levels.

Authors:  Hiroki Konishi; Koji Fukuzawa; Shumpei Mori; Seimi Satomi-Kobayashi; Kunihiko Kiuchi; Atsushi Suzuki; Yoshihiko Yano; Akihiro Yoshida; Ken-Ichi Hirata
Journal:  Intern Med       Date:  2017-07-15       Impact factor: 1.271

6.  Deviations in Peripheral Blood Cell Populations are Associated with the Stage of Primary Biliary Cholangitis and Presence of Itching.

Authors:  Halina Cichoż-Lach; Ewelina Grywalska; Agata Michalak; Agnieszka Kowalik; Michał Mielnik; Jacek Roliński
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2018-06-27       Impact factor: 4.291

7.  The extrahepatic events of Asian patients with primary biliary cholangitis: A 30-year cohort study.

Authors:  Cheng-Yu Lin; Ya-Ting Cheng; Ming-Ling Chang; Rong-Nan Chien
Journal:  Sci Rep       Date:  2019-05-20       Impact factor: 4.379

8.  Evaluation of Inhibitory Antibodies against the Muscarinic Acetylcholine Receptor Type 3 in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis.

Authors:  Anne-Christin Beatrice Wilde; Lena Maria Greverath; Lara Marleen Steinhagen; Nina Wald de Chamorro; Elise Leicht; Janett Fischer; Toni Herta; Thomas Berg; Beate Preuss; Reinhild Klein; Frank Tacke; Tobias Müller
Journal:  J Clin Med       Date:  2022-01-28       Impact factor: 4.241

9.  A high bile acid environment promotes apoptosis and inhibits migration in pancreatic cancer.

Authors:  Shaopu Zhu; Kang Yang; Shiyi Yang; Li Zhang; Maoming Xiong; Jiawei Zhang; Bo Chen
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.